Licensing Red/ET recombination
Gene Bridges GmbH owns the exclusive rights to Red/ET recombination and issues licenses for the use of the Red/ET Recombination technology to commercial users. Licensing arrangements for Red/ET recombination are provided as world-wide, non-exclusive sub-licenses.
Full commercial license (standard format)
Gene Bridges can customize full licenses to include access to any combination of the following applications:
cloning & subcloning
knock-out & knock-in constructs
strain modification & optimisation
They can be tailored to fit your requirements!
For more information please contact email@example.com